Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Pontifícia Universidade Católica do Paraná, Universidade Federal do Rio de Janeiro
Enrollment target
~34 participants
Primary completion
August 2020
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2022